FDA to hear comments on clinical investigations
This article was originally published in Clinica
Executive Summary
The US FDA is holding a public hearing on July 20th on the proposed regulation which would require clinical investigators to disclose financial interests. As a result of the 47 comments on the proposed regulation, the agency has decided to provide interested parties the opportunity to address the issues raised.